The Influence of Early Measurements Onto the Estimated Kidney Dose in [(177)Lu][DOTA(0),Tyr(3)]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine Tumors.
about
Software-assisted dosimetry in peptide receptor radionuclide therapy with 177Lutetium-DOTATATE for various imaging scenarios.Dosimetry methods and clinical applications in peptide receptor radionuclide therapy for neuroendocrine tumours: a literature reviewPatient-specific image-based bone marrow dosimetry in Lu-177-[DOTA,Tyr]-Octreotate and Lu-177-DKFZ-PSMA-617 therapy: investigation of a new hybrid image approach
P2860
The Influence of Early Measurements Onto the Estimated Kidney Dose in [(177)Lu][DOTA(0),Tyr(3)]Octreotate Peptide Receptor Radiotherapy of Neuroendocrine Tumors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
The Influence of Early Measure ...... rapy of Neuroendocrine Tumors.
@en
type
label
The Influence of Early Measure ...... rapy of Neuroendocrine Tumors.
@en
prefLabel
The Influence of Early Measure ...... rapy of Neuroendocrine Tumors.
@en
P2093
P2860
P1476
The Influence of Early Measure ...... rapy of Neuroendocrine Tumors.
@en
P2093
Andreas Delker
Christian Zach
Franz Josef Gildehaus
Guido Böning
Harun Ilhan
Julia Brosch
Peter Bartenstein
Sebastian Lehner
P2860
P2888
P304
P356
10.1007/S11307-015-0839-3
P577
2015-03-20T00:00:00Z
P5875
P6179
1035396952